STAT6 and STAT1 Pathway Activation in Circulating Lymphocytes and Monocytes as Predictor of Treatment Response in Rheumatoid Arthritis

Open Access

Peer-reviewed

Research Article

Krista Kuuliala ,

* E-mail: krista.kuuliala@gmail.com

Affiliation Bacteriology and immunology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland
⨯
Antti Kuuliala,

Affiliation Bacteriology and immunology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland
⨯
Riitta Koivuniemi,

Affiliation Rheumatology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland
⨯
Hannu Kautiainen,

Affiliations Primary Health Care, Helsinki University Hospital and University of Helsinki, Helsinki, Finland, General Practice, Helsinki University Hospital and University of Helsinki, Helsinki, Finland, Unit of Primary Health Care, Kuopio University Hospital, Kuopio, Finland
⨯
Heikki Repo,

Affiliation Bacteriology and immunology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland
⨯
Marjatta Leirisalo-Repo

Affiliation Rheumatology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland
⨯

Reader Comments (0)

Rheumatoid arthritis
Is the Subject Area "Rheumatoid arthritis" applicable to this article?

Thanks for your feedback.
Phosphorylation
Is the Subject Area "Phosphorylation" applicable to this article?

Thanks for your feedback.
Lymphocytes
Is the Subject Area "Lymphocytes" applicable to this article?

Thanks for your feedback.
Monocytes
Is the Subject Area "Monocytes" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Cytokine therapy
Is the Subject Area "Cytokine therapy" applicable to this article?

Thanks for your feedback.
STAT signaling
Is the Subject Area "STAT signaling" applicable to this article?

Thanks for your feedback.
Cytokines
Is the Subject Area "Cytokines" applicable to this article?

Thanks for your feedback.